COMP <GO>
AMGN vs UNH // OPERATING MARGIN
Amgen Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: AMGN 9
— UNH 6
▲ OPERATING MARGIN LEADER: AMGN
LAST: $466.01 (+1.15%) • MKT CAP: $249.09B
operating-margins
24.70%
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
operating-margins
4.82%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AMGN VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AMGN | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 67.20% | 88.57% | -21.37 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.50% | 11.47% | +3.03 | AMGN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 27.2x | 16.4x | +10.75 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 3.25% | 6.48% | -3.23 | UNH | /fcf-yield <GO> |
| Operating Margin ACTIVE | 24.70% | 4.82% | +19.88 | AMGN | /operating-margins <GO> |
| Net Profit Margin | 21.00% | 3.14% | +17.86 | AMGN | /net-margins <GO> |
| Revenue Growth (YoY) | 10.00% | 6.46% | +3.54 | AMGN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.06% | 2.28% | -0.22 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.83 | 3.12 | +0.71 | AMGN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | AMGN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.74% | -0.24 | AMGN | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 71.4 | 56.0 | +15.38 | AMGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.87 | 0.33 | +0.54 | AMGN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.0x | 17.1x | +12.91 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $249.09B | $364.66B | -$115.57B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AMGN REV | UNH REV | AMGN GROSS % | UNH GROSS % | AMGN FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $36.75B | $447.57B | 67.2% | 88.7% | $8.10B | $16.07B |
| FY 2024 | $33.42B | $400.28B | 61.5% | 88.3% | $10.39B | $20.70B |
| FY 2023 | $28.19B | $371.62B | 44.0% | 89.6% | $7.20B | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AMGN // BETA 0.87
UNH // BETA 0.33